BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $45,742,011 | +77.2% | 723,766 | +26.2% | 0.05% | +68.8% |
| Q1 2023 | $25,808,244 | +363498.8% | 573,644 | +254.0% | 0.03% | +220.0% |
| Q4 2022 | $7,098 | -100.0% | 162,029 | -54.5% | 0.01% | -71.4% |
| Q3 2022 | $23,445,000 | +15.2% | 355,817 | -11.7% | 0.04% | +25.0% |
| Q2 2022 | $20,343,000 | -52.3% | 402,742 | -39.6% | 0.03% | -41.7% |
| Q1 2022 | $42,607,000 | -62.7% | 666,992 | -37.5% | 0.05% | -57.9% |
| Q4 2021 | $114,245,000 | +19.4% | 1,066,612 | +14.6% | 0.11% | +7.5% |
| Q3 2021 | $95,718,000 | – | 931,016 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |